Upload
essonline
View
893
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Citation preview
SeizuresOlivia Jagger
Academic Education F2
Learning Objectives
Define what we mean by seizures
Demonstrate achievement of learning objectives through
clinical cases
Understand the different types of seizures
Understand the causes of seizures
Know the emergency and longterm management of seizures
Know the complications of seizures and their management
Definitions - what does it all mean?
SeizureStatus
Epilepticus
Epilepsy
spontaneous uncontrolled
abnormal brain activity
Seizure >20 - 30minutes
OR
Multiple seizures frequent enough to prevent recovery between
episodes >20-30mins
tendency to have spontaneous uncontrolled
abnormal brain activity,
resulting in recurrent seizures
Pathophysiology
Action Potential
Pre-synaptic membrane
Post-synaptic membrane
Action Potential
excitatory
neurotransmitter
Ca2+
Na+
inhibitory
neurotransmitter
Pathophysiology
Glutamate is the major excitatory
neurotransmitter
GABA (gamma-
aminobutyric acid) is the
main inhibitory
neurotransmitter
Pathophysiology
Seizures are caused by abnormal synchronised
discharge of many neurons
Every individual has a seizure threshold
- the level of
excitability at which neurons will discharge
uncontrollably
In patients with epilepsy the seizure threshold is lowered and the neurons are
hyperexcitable
Triggers that push neuron excitationpast the seizure threshold include:
‣ Sleep deprivation
‣ Drugs
‣ Flickering lights‣ Infection / metabolic
disturbance
CauseIntracranial Extracranial
Underlying brain abnormality Pyrexia
• Raised intracranial pressure - cerebral tumour - cerebral odema → pregnant - eclampsia
Hypoxia
• Stroke - Thrombo-embolic - Haemorrhagic
• Biochemical ↑↓Sodium, Glucose ↓ Calcium, Magnesium ↑ Urate
Brain infections• Drugs - Prescribed / Recreational - Intoxication / Withdrawal
Intracranial Extracranial
Types of seizures
Absence
Myoclonic
Tonic-Clonic Tonic Atonic
Partial Generalised
Seizures
Simple Complex
no loss of conciousness
conciousness impaired
specific area in one cerebral hemisphere
both cerebral hemispheres
Tonic Clonic Seizures
• Prodrome• Aura• Sudden onset• Triggers
•Tonic Phase: stiffening, loss of consciousness, falls, cries out
• Clonic Phase: convulsion, jerking of arms and legs
•Excessive salivation (drooling or foaming)
•Biting of the tongue
•Loss of bowel and/or bladder control
•No breathing / random breaths
•Eye rolling
• Post-ictal• Drowsy• Confused• Agitated
Before During After
Convulsive seizure with tonic phase (stiffening) and clonic movements (jerking)
Febrile convulsions
• most common seizure disorder in childhood
• Peak age of onset 14-18 months
• Pyrexial
• Tonic-clonic
• <10 mins
• Don’t predispose to epilepsy
• ABCDE
• Rule out underlying infection
• Paediatric review if first fit
• REASSURE parents!
Presentation Management Risk Factors for Epilepsy
• First fit <9months
• Atypical seizure
• FH epilepsy
• Evidence of developmental delay
• Abnormal neurology on examination
Emergency Management
You are the F1 on call and you’re bleeped...
What is your initial management?
“Please come quickly a patient is having a
seizure and we don’t know what to do!”
Emergency Management
A
B
C
D
Airway
Breathing
Circulation
Disability
• Patent?• Give airway support if needed
• RR• O2 sats• give O2
• HR• BP• Cap refill• IV access and bleed• Head injury?• Infection?• Bleeding?• Temperature?• BM?
Start treating underlying cause
Management of seizuresStepwise approach
Benzodiazepine
Start treating underlying cause
Initial A,B, C, D
Phenytoin
Paralysis and Ventilation
Action Potential
Action Potential
Benzodiazepine - mechanism of action
If seizure does not resolve after a few minutes give a benzodiazepine
Reduces excessive neuronal firing
Enhances the inhibitory effect of GABAGAB
A
Benzodiazepines
Lorazepam 0.1mg/kg IV (2-4mg bolus repeated after 15 mins)
Diazepam 10-20mg rectally (repeated after 15 mins)
Midazolam 10mg buccally (repeated after 15 mins)
First lineIV Access
Second lineNo Access
Side Effects
• sedation• suppressed breathing• hypotension (worse with IV)
Management of seizuresStepwise approach
Phenytoin
Initial A,B, C, D
Paralysis and Ventilation
Benzodiazepine
Start treating underlying cause
Phenytoin - mechanism of action
Action Potential
Action Potential
Inhibits excitatory neuronal
transmission
Blocks voltage-sensitive sodium channels
If seizure does not resolve after benzodiazepine start a phenytoin infusion
Na+
Infusion dose
20mg/kg over 20 minutes
Phenytoin - Pharmacokinetics
Continuous BP and ECG monitoring
• Mainly hepatic break down• Zero order kinetics• Narrow therapeutic range• Risk of toxicity
Phenytoin - Side Effects
•Gum hypertrophy•Nausea / vomiting
•Headaches•Skin rashes•Hypotension
•Arrhythmias (bradycardia)•Bone marrow suppression
- Megaloblastic anaemia•Teratogenicity
•Ataxia•Nytagmus•Drowsiness•Dysphasia
•Coma death•Arrhythmias (bradycardia)•Hypotension
Monitor serum levels, FBC, LFTsIf IV: BP and ECG (especially QT
interval)
At therapeutic levels At toxic levels
Management of seizuresStepwise approach
Initial A,B, C, D
Paralysis and Ventilation
Benzodiazepine
Start treating underlying cause
Phenytoin
If seizure not resolved following initial
management patient may need paralysis and
ventilation
Should be done in ITU by an expert
* Never spend long than 20 minutes with a patient with a seizure before calling an
anaesthetist! *
Longterm Management - Drugs
Absence
Myoclonic
Tonic-Clonic Tonic Atonic
Partial Generalised
Seizures
Simple Complex1st line carbamazepine /2nd line sodium valproate
1st line sodium valproate /
2nd line levetiracetam
1st line sodium valproate /
2nd line lamotrigine1st line sodium valproate
1st line sodium valproate /
2nd line levetiracetam
1st line sodium valproate /
2nd line lamotrigine
1st line sodium valproate
1st line carbamazepine /2nd line sodium valproate
1st line sodium valproate /
2nd line ethosuximide
1st line sodium valproate /
2nd line ethosuximide
Summary of longterm drug therapy
Type of Seizure 1st line drug 2nd line drug
PARTIAL Simple and
Complex
Carbamazepine(Inhibits sodium channels reducing action potential
propagation )
Sodium Valproate
GENERAL
Absence Sodium Valproate(Inhibits GABA
transaminase so enhances inhibitory affect
of GABA)
Ethosuximide (Calcium channel
inhibitor)
Myoclonic
Sodium Valproate Levetiracetam(Mechanism of
action unknown)
Tonic-Clonic
Sodium Valproate Lamotrigine(Inhibits sodium
channels reducing action potential
propagation)
Tonic Sodium Valproate
Atonic Sodium Valproate
Sodium Valproate - mechanism of action
Action Potential
Action Potential
Reduces excessive neuronal firing
Enhances the inhibitory effect of GABAGABA
Inhibits GABA transaminase (inhibits GABA breakdown)
Sodium Valproate - side effects
• Thinning and curling of hair• Hepatotoxicity (P450 inhibitor)• Weight gain• Thrombocytopaenia• Pancreatitis• Teratogenicity
•Significantly increased risk of birth defects with
Sodium Valproate
•The relative risk is 2-5x higher than other antiepileptic drugs
•Extreme caution in women of childbearing age
At therapeutic levels In Pregnancy
Cytochrome P450 Enzymes
• P450 cytochromes are the major enzymes involved in drug metabolism
• mainly act in the liver
INHIBITORS
Sodium Valproate
INDUCERS
Phenytoin / Carbamazapine
P450 inducers speed up the metabolism of drugs
(decrease drug availability)
P450 inhibitors lead to build up of
unmetabolised drugs (increase drug
availability)
Longterm Management - Surgery
Surgery may be considered when there is:
•A mass lesion in the brain•Uncontrolled epilepsy
Living well with Epilepsy
• Safety Advice
• Ensure treatment compliance
• Have a predetermined plan for seizure emergencies and rescue treatment
• First fit - cannot drive for 6 months
• Second or further fits - cannot drive for 12 months
• Medication change in the last 6 months - cannot drive for 6 months
• ‘night-time’ only seizures - they can drive, if they have not had a ‘day time’ seizure for 3 years
Lifestyle Driving
Todd’s Paresis
Complications
Brain Injury
Physical Injury
Sudden Unexpected Death in Epilepsy
Clinical Case 1
• A 70kg 27 year old male presents with five minutes of generalised tonic-clonic seizures.
• The immediate management would be:
A. 4mg Lorazepam IV
B. Maintain a clear airway
C. Call an anaesthetist
D. 20mg Diazepam rectally
Clinical Case 1
• Following an ABCD assessment, with attainment of IV access, he continues to fit.
• The appropriate management would be:
A. Lorazepam IV
B. Phenytoin IV
C. Midazolam buccally
D. Diazepam rectally
Clinical Case 1
• 20 minutes after the administration of 4mg lorazepam he continues to fit.
• The appropriate management would be:
A. Lorazepam IV
B. Phenytoin IV
C. Move to ITU for paralysis and assisted ventilation
D. hold him down to prevent injury
Clinical Case 1• His seizure resolves with an IV Phenytoin infusion. Baseline
investigations are unremarkable. He is discharged home for follow up in the ‘first fit’ clinic.
• What advice should he be given about driving?
A. He cannot drive for 6 months
B. He cannot drive for 12 months
C. He can continue to drive until he has been reviewed by a Neurologist in clinic
D. He cannot drive again until he retakes his driving test
Clinical Case 2An ambulance brings a 15 month old boy to ED following a seizure.
His mother reports he suddenly started shaking his arms and legs and his eyes had a blank stare. This went on for what seemed like 5 minutes so she called 999. There is no vomiting, diarrhea or rash. He has no significant past medical history.
O/E Temperature 39C, slight cough and mild nasal congestion. Alert and interactive. Normal neurological examination.
The immediate management would be:
• Maintain a clear airway
• 10mg Diazepam rectally
• 5mls Calpol
• IV access and bloods
Clinical Case 2He was reviewed by a Paediatrician who found no evidence of
developmental delay or systemic infection. His temperature settled with Calpol.
The likely diagnosis is:
• Epilepsy
• Febrile Convulsion
A.Absence Seizure
B.Brain tumour
Clinical Case 2
• Which of the following are Risk Factors for development of epilepsy in febrile convulsions:
• (select as many as apply)
A. Family history of a febrile convulsion
B. Generalised seizure
C. Recurrent febrile seizures
D. Febrile seizure onset in first nine months
E. Evidence of developmental delay
Clinical Case 3•An 85 year old gentleman is brought in by his grandson with acute confusion and frank haematuria.
•Past medical history: Hypertension, Hypercholesterolaemia, AF and Epilepsy
•Drug History: Warfarin, Simvastatin, Sodium Valproate
•Which one initial investigation will most aid your diagnosis?
• Sodium Valproate level
• INR
• CT head
• Cystoscopy
Clinical Case 3
• Which of the following anti-epileptic drugs are INDUCERS of P450 cytochromes?
• (select as many apply)
A. Phenytoin
B. Carbamazepine
C. Sodium Valproate
D. Lamotrigine
Clinical Case 4
• A 37 year old man presented to the Emergency department following an epileptic seizure. He had suffered from epilepsy since childhood and takes sodium valproate and levertiracetam. Two hours following the seizure he complained that he was still unable to move his right arm.
• The likely diagnosis is:
A. Partial Seizure
B. Todd’s Paresis
C. TIA
D. Stroke
Clinical Case 4
• Which of the following statements are correct about Todd’s Paresis?
• (select as many as apply)
A. There is paralysis of limbs lasting several hours after a seizure
B. It is a type of lower motor neurone paralysis
C. It has to be differentiated from acute stroke
D. It usually resolves within 1-2 weeks
E. It is associated with dysphasia
AMK practice
• The most appropriate longterm drug for treatment of generalised tonic-clonic seizures is:
A. Sodium valproate
B. Lamotrigine
C. Ethosuximide
D. Carbemazepine
E. Lorazepam
AMK practiceThe most appropriate longterm drug for treatment of complex partial
seizures is:
(Select as many as apply)
• Phenytoin
A. Sodium valproate
B. Carbamazepine
B. Ethosuximide
C. Lamotrigine
AMK practice• A 30 year old lady is started on phenytoin for recurrent
tonic-clonic seizures. Past medical history includes prednisolone for brittle asthma. Two weeks later she returns to clinic and complains that her asthma has worsened since she began the phenytoin therapy.
• A likely reason for this new change is that phenytoin:
• interferes with absorption of the prednisone
• stabilizes cell membranes, preventing the prednisone from diffusing tothe site of action
• accelerates hepatic degradation of prednisone
• induce renal excretory pathways, accelerating urinary excretion of theprednisone
• Decreases hepatic degradation of prednisolone
AMK practice
• Select 3 drugs with similar proposed mechanisms of action:
A. Phenytoin
B. Carbamazepine
C. Lamotrigine
D. Sodium valproate
E. Ethosuximide
AMK practice• Which of the following statements about Phenytoin are
true:
• (select as many as apply)
A. It follows first-order kinetics
B. It follows zero-order kinetics
C. It is mainly metabolised by the kidneys
D. It has a narrow therapeutic window
E. It can cause bone marrow suppression
AMK practice• Symptoms of Phenytoin toxicity include:
• (select as many as apply)
A. Gingival hyperplasia
B. Nystagmus
C. Ataxia
D. Dysphasia
E. Bone marrow suppression
Seizures SummarySeizures are caused by abnormal synchronised discharge of many neurons
Seizures are classified as Partial (affect a small area of one cerebral hemisphere) and Generalised (affecting both cerebral hemispheres)
Anything that lowers the excitation threshold of neurons (makes them hyper excitable or reduces inhibition) can result in seizures
A seizure is an emergency ‘Status Epilepticus’ if it lasts >20 - 30minutes OR multiple seizures frequent enough to prevent recovery >20-30mins
The stepwise management of seizures is ABCD assessment, Benzodiazepine, Phenytoin, Paralysis and assisted ventilation
The first line drug for longterm management of generalised seizures is Sodium Valproate
The first line drug for the longterm management of partial seizures is Carbamazepine
Phenytoin displays zero-order kinetics and has potential for toxicity
Sodium Valoprate is 2-5x more teratogenic than any other anti-epileptic agent